Granulomatous mastitis is an inflammatory disease that develops in breast tissue and can occasionally cause clinical symptoms similar to breast cancer. The disease may be confused with breast cancer, especially as it may present with findings such as a hard mass in the breast, redness, pain, skin changes and swelling. Although granulomatous mastitis is a benign breast disease, it can cause long-lasting complaints, recurrent inflammation and problems affecting the quality of life in some patients. For this reason, it is important to diagnose the disease correctly and plan the treatment individually.
General Surgery Specialist Prof. Dr. Ebru Ayvazoğlu Soy emphasizes that granulomatous mastitis can mimic breast cancer with clinical examination and imaging findings, so a definitive diagnosis should not be made based on symptoms alone.
Clinical evaluation, breast ultrasonography, mammography and tissue biopsy when necessary have an important place in the diagnosis of granulomatous mastitis. Pathological examination helps to make a differential diagnosis with breast cancer, especially in patients with suspicious findings in imaging methods. Correct diagnosis is of great importance in preventing unnecessary surgical procedures and determining the appropriate treatment method.
Granulomatous mastitis is a disease characterized by the formation of special inflammatory cell communities called granulomas in the breast tissue. Although it is mostly seen in women of reproductive age, it can also occur in different age groups.
The mechanism of the disease cannot always be determined with certainty. It is thought that in some cases, the abnormal inflammatory response of the immune system to the breast tissue may be effective.
Hormonal factors, pregnancy and breastfeeding history, changes in the milk ducts and some microorganisms may play a role in the development of granulomatous mastitis.
It is known that especially Corynebacterium type bacteria are associated with some cases of granulomatous mastitis. However, bacterial infection is not detected in every patient.
Granulomatous mastitis should be distinguished from granulomatous inflammations that develop for different reasons. Infections such as tuberculosis, some systemic inflammatory diseases and other rare conditions may produce similar pathological findings.
Therefore, determining only granulomatous inflammation may not be sufficient in the evaluation of the disease. It is also important to investigate the underlying causes.
Idiopathic granulomatous mastitis is the definition used for cases in which no obvious cause can be detected.
The disease is not a contagious type of cancer and is not considered breast cancer on its own. However, the clinical picture it creates may be similar to serious diseases.
The main reason why granulomatous mastitis is confused with breast cancer is that a hard mass can form in the breast tissue in both diseases.
The inflammatory process that develops in granulomatous mastitis can create hardness with irregular borders in the breast tissue. While these stiffnesses may be painful in some patients, there may be no significant pain in some patients.
Changes such as redness, thickening and retraction of the breast skin may be observed. These findings may also occur in some types of breast cancer.
In particular, inflammatory breast cancer may manifest itself with symptoms such as redness, swelling and thickening of the breast skin. For this reason, differential diagnosis should be made carefully in patients suggesting granulomatous mastitis.
Breast ultrasonography may reveal areas with irregular borders, heterogeneous structure, or extending into surrounding tissues. This appearance may be similar to some malignant tumors.
Asymmetric density increase, mass or other suspicious changes may also be seen on mammography.
Bypsy is an important diagnostic tool because imaging findings cannot always clearly distinguish the type of disease.
Prof. Dr. Ebru Ayvazoğlu Soy points out that symptoms that may suggest cancer in the breast tissue should not be evaluated solely with the assumption of inflammatory disease.
Further examination is important, especially if the complaints continue despite treatment, the mass grows or the imaging results are suspicious.
One of the most common symptoms in granulomatous mastitis is the formation of a painful or painless mass in the breast. The mass is most often seen in one breast, but rarely, the disease may develop in both breasts.
Tenderness, redness and swelling may occur in the breast tissue. In some patients, inflammatory areas develop near the skin surface.
In the later stages of the disease, abscess formation or draining pathways opening to the skin may occur. These formations, called fistulas, can cause long-term discharge and recurrent complaints.
In some patients, enlargement of the armpit lymph nodes may also develop. Although this condition is mostly associated with the inflammatory response, it requires evaluation.
Granulomatous mastitis does not have the same severity in every patient. While some people experience mild symptoms in a limited area, some people may develop an inflammatory process affecting large breast tissue.
It is possible for complaints to decrease or increase again from time to time. While the disease may regress spontaneously in some cases, it may continue for months in others.
A significant change in the shape of the breast tissue may cause patients to be affected both physically and psychologically.
For this reason, granulomatous mastitis should not be considered as a simple condition consisting only of infection-like symptoms.
The first stage in the diagnosis of granulomatous mastitis is a detailed clinical evaluation. The duration of the patient's complaints, history of pregnancy and breastfeeding, previous breast diseases and medications used may be questioned.
During the physical examination, the location of the mass, changes in the breast skin and areas with discharge are evaluated.
Breast ultrasonography plays an important role in determining inflammatory areas and possible abscesses. Mammography may also be performed depending on the patient's age and clinical characteristics.
However, imaging methods cannot always confirm the diagnosis of granulomatous mastitis. It may be necessary to take a tissue sample to make a differential diagnosis with breast cancer.
Thin needle biopsy is one of the important methods that enable pathological evaluation of breast tissue.
In pathological examination, findings of granulomatous inflammation are investigated. When necessary, infectious causes are evaluated with special stains, microbiological cultures or other tests.
It is important that clinical, radiological and pathological findings are compatible with each other during the diagnosis process.
If the biopsy result does not explain the imaging findings, resampling or additional examinations may be required.
This approach helps prevent possible breast cancer from being overlooked and unnecessary treatment due to misdiagnosis.
Treatment of granulomatous mastitis depends on the severity of the disease, It is planned according to its prevalence and possible underlying causes.
Close follow-up and supportive treatment may be preferred in some patients with mild symptoms. Because the disease may regress spontaneously over time in certain cases.
Drug treatments may be considered in patients with painful and significant inflammatory findings.
Corticosteroids can be used to control the inflammatory process in suitable patients. However, since these drugs have side effects, the treatment must be planned under the supervision of a specialist physician.
In some resistant or recurrent cases, different drugs that regulate the immune system can be used.
In cases where bacterial infection is indicated, antibiotic treatment can be applied for the identified microorganism. However, antibiotic use is not necessary in every granulomatous mastitis patient.
Interventional procedures such as drainage may be required in patients who develop an abscess. However, surgical treatment is not the first option for every patient.
Extensive surgical removals may cause changes in breast shape and wound healing problems in some cases. Therefore, it is important to carefully evaluate the surgical decision.
Granulomatous mastitis may reoccur after treatment in some patients. The possibility of recurrence of the disease varies depending on the clinical features and treatments applied.
Re-evaluation should be made if a new mass or rash develops after the complaints have completely resolved.
Recurrent granulomatous mastitis does not always mean that cancer has developed. However, it is not correct to attribute newly emerging findings only to the previous disease.
It is important for patients to maintain regular check-ups, use the treatments as recommended, and follow the changes in the breast tissue.
The similarities between granulomatous mastitis and breast cancer require a careful approach in the diagnosis process. It is possible to distinguish these diseases from each other thanks to correct imaging, appropriate biopsy and pathological evaluation.
Early and accurate diagnosis contributes to the prevention of unnecessary surgical interventions, initiation of appropriate treatment and protection of the long-term breast health of patients.